Effectiveness and cost-effectiveness of combination therapy versus monotherapy in malignant melanoma

Figures & data

Fig. 1 PRISMA flowchart

Table 1 Overview of included randomized controlled trials

Table 2 Overview of the included cost–utility analyses

Availability of data and materials

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.